TABLE 1.
CHV detection and clinical specimens from inpatients at an animal referral center
| Dog identifier | Breeda | Sexb | Age (yr) | Vaccination recordc or date (yr.mo.day) | Clinical signd and outcome | Treatment |
Specimen (originf) | CHV detection |
||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Steroidse | Surgery | Chemotherapy | Radiation | VIg | PCR | |||||||
| 71923 | MDH | FS | 11 | 2007.11.10 | Coughing, pyrexia, recovery | Yes | Yes | 08/005 (N) | + | + | ||
| 08/006 (P) | − | + | ||||||||||
| 71995 | Shih tzu | F | 8 | Vaccinated | Pyrexia, sneezing, coughing, recovery | Yes | 08/009 (N) | − | − | |||
| 08/010 (P) | − | + | ||||||||||
| 71802 | Pomeranian | FS | 1 | 2007.9.1 | Pyrexia, sneezing, recovery | Yes | Yes | 08/011 (N) | + | + | ||
| 08/012 (P) | − | + | ||||||||||
| 71927 | Shih tzu | M | 12 | 2007.5.22 | Coughing, sneezing, nasal discharge, death | Yes | 08/013 (N) | − | − | |||
| 08/014 (P) | − | + | ||||||||||
| 71982 | MDH | M | 7 | 2007.9.21 | Sneezing, nasal discharge, recovery | Yes | 08/015 (N) | + | + | |||
| 08/016 (P) | − | + | ||||||||||
| 71579 | Mongrel | M | 10 | Unknown | Pyrexia, sneezing, recovery | Yes | 08/017 (N) | − | + | |||
| 08/019 (P) | − | + | ||||||||||
| 71917 | Shelty | M | 8 | Vaccinated | Vomiting, pyrexia, coughing, death | Yes | Yes | 08/021 (N) | + | + | ||
| 71993 | MDH | M | 7 | 2007.5.30 | Pyrexia, sneezing, nasal discharge, recovery | Yes | Yes | 08/022 (N) | − | + | ||
| 71947 | SSD | F | 9 | Vaccinated | Interstitial pneumonia, death | Yes | 08/026 (N) | − | + | |||
| 71705 | Yorky | M | 11 | 2007.5.23 | Diarrhea, nasal discharge, recovery | Yes | Yes | 08/027 (N) | − | + | ||
| 08/028 (P) | − | + | ||||||||||
a
MDH, miniature dachshund; Yorky, Yorkshire terrier; SSD, Shetland sheepdog.
b
F, female; M, male; FS, female spayed.
c
The last inoculation date with canine combined vaccines; vaccinated, vaccinated but the date of inoculation is unknown.
d
Clinical signs at the time of sampling.
e
Prednisolone at 0.25 to 5 mg/kg/day for 5 to 29 consecutive days.
f
N, nasal; P, pharyngeal.
g
VI, virus isolation with MDCK cell culture.